UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 12, 2016

KURA ONCOLOGY, INC.

(Exact name of Registrant as Specified in Its Charter)

Registrant’s Telephone Number, Including Area Code: (858) 500-8800

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

As reported below in Item 5.07, on May 12, 2016, the stockholders of Kura Oncology, Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, effective as of May 12, 2016, to provide that any of the Company’s directors or its entire Board of Directors may be removed, with or without cause, by the holders of a majority of the Company’s shares of common stock then entitled to vote at an election of directors. The amendment was filed with Secretary of State of the State of Delaware on May 12, 2016.

On May 12, 2016, the Company’s Board of Directors also approved the Company’s Amended and Restated Bylaws, to provide that any of its directors or its entire Board of Directors may be removed, with or without cause, by the holder of a majority of the Company’s shares of common stock then entitled to vote at an election of directors.

The foregoing description does not purpose to be complete and is qualified in its entirety by reference to the full text of the Amended and Restated Certificate of Incorporation, as amended, and to the Amended and Restated Bylaws, copies of which are filed as Exhibits 3.1 and 3.2 to this current report on Form 8-K and incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company held its Annual Meeting of Stockholders on May 12, 2016 (the “Annual Meeting”).  As of the close of business on March 17, 2016, the record date for the Annual Meeting, there were 21,370,560 shares of common stock outstanding, of which 18,598,009 shares of common stock were present in person or represented by proxy.  The final voting results were as follows:

Proposal 1.  Election of Directors

The Company’s stockholders elected the four directors listed below, each to hold office until the Company’s 2017 Annual Meeting of Stockholders and until their successors are duly elected and qualified, or until their earlier death, resignation or removal. The final voting results were as follows:

Proposal 2.  Ratification of the Selection of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the selection of Ernst & Young LLP by the Audit Committee of the Board as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016. The final voting results were as follows:

Proposal 3. Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation

The amendment to the Amended and Restated Certificate of Incorporation was approved by the following vote:

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Exhibit Index